Biotricity, Inc. (BTCY)
Biotricity, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Redwood City, CA, US. The stock last traded at $0.11, down 2.44% on the session, giving a market capitalisation of $2.1M. On trailing twelve-month figures it carries a trailing P/E of -0.94, a net margin of -15.0%. Its beta of 1.15 implies it has historically moved more than the broad market.
Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.
Biotricity, Inc. is most often compared with the following Healthcare names: